Association between human papillomavirus DNA and temporal arteritis

BMC Musculoskeletal Disorders

James S Lewis³  John D Pfeifer¹  Amir Mohammadi² 

[1] Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, Division of Anatomic and Molecular Pathology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA;Department of Pathology and Laboratory Medicine, University of Florida, College of Medicine, Jacksonville, Fl, USA;Department of Otolaryngology – Head and Neck Surgery, Washington University School of Medicine, St. Louis, MO, USA

关键词: Polymerase chain reaction;    Giant cell arteritis;    Human papillomavirus;   

Others  :  1149070
DOI  :  10.1186/1471-2474-13-132

 received in 2011-12-14, accepted in 2012-07-10,  发布年份 2012

【 摘 要 】

Background

To examine the relationship between human papillomavirus (HPV) and giant cell arteritis (GCA) of the temporal artery.

Methods

The study group consisted of 22 cases of histologically positive/biopsy confirmed GCA. The control groups consisted of 21 histologically negative temporal artery biopsies and fifteen cases of vascular margins of nephrectomies. For detection of the presence of HPV, two methods were used: 1) polymerase chain reaction (PCR) with INNO-LiPA HPV Genotyping Extra, 2) Cervista™ HPV HR. All cases were from the files of the Barnes-Jewish Hospital and Washington University in St. Louis.

Results

HPV DNA was detected by PCR and genotyping in 16 of 22 (73%) histologically positive cases of GCA and in only five of 21 (24%) histologically negative temporal artery biopsies. Among the vascular margin controls, only three of 15 (20%) were positive for HPV DNA. The second, independent method (Cervista^TM) confirmed the aforesaid results with 100% concordance with the exception of three cases which had low genomic DNA for which it was not possible to perform the test. The differences in HPV positivity between the histologically positive and negative temporal artery biopsies and between the histologically positive temporal artery biopsies and controls were both statistically significant (p = 0.001 and 0.002, respectively).

Conclusions

The results of our study revealed a statistically significant association between HPV positivity and biopsy confirmed temporal giant cell arteritis GCA (p = 0.001). Further studies are necessary to elucidate the pathophysiology underlying this association.

【 授权许可】

   
2012 Mohammadi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 5.

【 参考文献 】

• [1]Burke A, Virmani R: Blood Vessels. In Sternberg's Diagnostic Surgical Pathology. Volume 1. 5th edition. Edited by Mills SE. Philadelphia: Lippincott Williams & Wilkins; 2009:1236-1238.
• [2]Smetana GW, Shmerling RH: Does this patient have temporal arteritis? JAMA 2002, 287(1):92-101.
• [3]Gordon LK, Levin LA: Visual loss in giant cell arteritis. JAMA 1998, 280(4):385-386.
• [4]Font C, Cid MC, Coll-Vinent B, Lopez-Soto A, Grau JM: Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 1997, 36(2):251-254.
• [5]Liu GT, Glaser JS, Schatz NJ, Smith JL: Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994, 101(11):1779-1785.
• [6]Hellmann DB: Temporal arteritis: a cough, toothache, and tongue infarction. JAMA 2002, 287(22):2996-3000.
• [7]Fule T, Mathe M, Suba Z, Csapo Z, Szarvas T, Tatrai P, Paku S, Kovalszky I: The presence of human papillomavirus 16 in neural structures and vascular endothelial cells. Virology 2006, 348(2):289-296.
• [8]Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J: Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009, 61(10):1454-1461.
• [9]Elkind MS: Inflammatory markers and stroke. Curr Cardiol Rep 2009, 11(1):12-20.
• [10]Ma Z, Liu L, Zhang F, Yu M, Wang K, Luo J, Liu K, Chen B, Xu L: Human papillomavirus type 16 exists in bacteria isolated from cervical cancer biopsies. J Int Med Res 2009, 37(4):1065-1074.
• [11]Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, et al.: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33(8):1122-1128.
• [12]Third Wave Technologies, The Cervista TM HPV HR. http://www.cervistahpv.com/pdf/Cervista_HPV_HR_PI_15-3100_Rev_C.pdf webcite
• [13]Weyand CM, Schonberger J, Oppitz U, Hunder NN, Hicok KC, Goronzy JJ: Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 1994, 179(3):951-960.
• [14]Cooper RJ, D'Arcy S, Kirby M, Al-Buhtori M, Rahman MJ, Proctor L, Bonshek RE: Infection and temporal arteritis: a PCR-based study to detect pathogens in temporal artery biopsy specimens. J Med Virol 2008, 80(3):501-505.
• [15]Wagner AD, Gerard HC, Fresemann T, Schmidt WA, Gromnica-Ihle E, Hudson AP, Zeidler H: Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 2000, 43(7):1543-1551.
• [16]Elling P, Olsson AT, Elling H: Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 1996, 23(1):112-119.
• [17]Powers JF, Bedri S, Hussein S, Salomon RN, Tischler AS: High prevalence of herpes simplex virus DNA in temporal arteritis biopsy specimens. Am J Clin Pathol 2005, 123(2):261-264.
• [18]Cankovic M, Zarbo RJ: Failure to detect human herpes simplex virus, cytomegalovirus, and Epstein-Barr virus viral genomes in giant cell arteritis biopsy specimens by real-time quantitative polymerase chain reaction. Cardiovasc Pathol 2006, 15(5):280-286.
• [19]Rodriguez-Pla A, Bosch-Gil JA, Echevarria-Mayo JE, Rossello-Urgell J, Solans-Laque R, Huguet-Redecilla P, Stone JH, Vilardell-Tarres M: No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis. J Clin Virol 2004, 31(1):11-15.
• [20]Helweg-Larsen J, Tarp B, Obel N, Baslund B: No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 2002, 41(4):445-449.
• [21]Njau F, Ness T, Wittkop U, Pancratz T, Eickhoff M, Hudson AP, Haller H, Wagner AD: No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods. J Clin Microbiol 2009, 47(6):1899-1901.
• [22]Haugeberg G, Bie R, Nordbo SA: Chlamydia pneumoniae not detected in temporal artery biopsies from patients with temporal arteritis. Scand J Rheumatol 2000, 29(2):127-128.
• [23]Nordborg C, Nordborg E, Petursdottir V, LaGuardia J, Mahalingam R, Wellish M, Gilden DH: Search for varicella zoster virus in giant cell arteritis. Ann Neurol 1998, 44(3):413-414.
• [24]Cuschieri KS, Cubie HA, Whitley MW, Gilkison G, Arends MJ, Graham C, McGoogan E: Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 2005, 58(9):946-950.
• [25]Zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2(5):342-350.
• [26]Gillison ML: Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004, 31(6):744-754.
• [27]Masini C, Fuchs PG, Gabrielli F, Stark S, Sera F, Ploner M, Melchi CF, Primavera G, Pirchio G, Picconi O, Petasecca P, Cattaruzza MS, Pfister HJ, Abeni D: Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003, 139(7):890-894.
• [28]Gnanamony M, Peedicayil A, Subhashini J, Ram TS, Rajasekar A, Gravitt P, Abraham P: Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer. Gynecol Oncol 2010, 116(3):447-451.
• [29]Ho CM, Yang SS, Chien TY, Huang SH, Jeng CJ, Chang SF: Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients. Gynecol Oncol 2005, 99(3):615-621.
• [30]Wei YC, Chou YS, Chu TY: Detection and typing of minimal human papillomavirus DNA in plasma. Int J Gynaecol Obstet 2007, 96(2):112-116.
• [31]Dong SM, Pai SI, Rha SH, Hildesheim A, Kurman RJ, Schwartz PE, Mortel R, McGowan L, Greenberg MD, Barnes WA, Sidransky D: Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev 2002, 11(1):3-6.
• [32]Yang HJ, Liu VW, Tsang PC, Yip AM, Tam KF, Wong LC, Ng TY, Ngan HY: Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int J Gynecol Cancer 2004, 14(5):903-910.
• [33]Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM: Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42(2):311-317.